Skip to Main Content

Paper Details

Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists.
1
2023
D536G, GLP-1, GLP-1 Receptor, GLP-1 receptor, GLP-1R, Patients, Peptidyl, Peptidyl-glycine Alpha-amidating Monooxygenase, S539W, T2D, Type 2 Diabetes, gastric GLP-1R, glucose, glycated, glycine, hemoglobin, human, hypomorphic alleles, incretin, mice, p, peptidyl, peptidyl-glycine alpha-amidating monooxygenase, type 2 diabetes
Author NameAffiliation
Benoit HastoyUniversity of Oxford
Soren K ThomsenUniversity of Oxford
Anna JonssonCopenhagen University Hospital - Steno Diabetes Center Copenhagen
Niels GrarupCopenhagen University Hospital - Steno Diabetes Center Copenhagen
Christian T HaveCopenhagen University Hospital - Steno Diabetes Center Copenhagen
Anette P GjesingCopenhagen University Hospital - Steno Diabetes Center Copenhagen
Matt J NevilleUniversity of Oxford
Matt J NevilleNational Institute of Health Research, Oxford Biomedical Research Centre, Churchill Hospital
Oluf PedersenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Mark WalkerTranslational and Clinical Research Institute, Newcastle University
Andrew T HattersleyUniversity of Exeter College of Medicine & Health
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Fredrik KarpeUniversity of Oxford
Fredrik KarpeNational Institute of Health Research, Oxford Biomedical Research Centre, Churchill Hospital
Mark I McCarthyUniversity of Oxford
Mark I McCarthyNational Institute of Health Research, Oxford Biomedical Research Centre, Churchill Hospital
Mark I McCarthyUniversity of Oxford
Anna L GloynUniversity of Oxford
Anna L GloynStanford School of Medicine
Anna L GloynNational Institute of Health Research, Oxford Biomedical Research Centre, Churchill Hospital
Anna L GloynUniversity of Oxford
Anna L GloynStanford Diabetes Research Centre
  • 1 - 22

Datasets